 Cherry Hill, N.J.,, Nov. 29, 2021 GLOBE NEWSWIRE -- Vyant Bio, Inc. Vyant Bio, the Company Nasdaq: VYNT, an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system CNS and oncology-related diseases. Today, Vyant Bio announced that it will be participating in The Benchmark Company Discovery One-on-One Investor Conference. The event is being held virtually on Thursday, December 2, 2021. 